A Study to Create a Registry for Patients at High-Risk for Pancreatic Cancer


About this study

This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC). and to facilitate the use of state-of-the-art machine learning-based algorithms that utilize databases and images with the purpose of identifying early stages of pancreatic cancer, as well as people at high-risk.The study also aims to provide a platform for development of an interventional protocol for early detection of PDAC.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • Age ≥ 18 years.
  • Able to provide written informed consent.
  • Meets criteria as a High-Risk Individual as defined by protocol.

 Exclusion Criteria: 

  • Individuals less than 18 years.
  • Individual who has a personal history of pancreatic ductal adenocarcinoma (PDAC).
  • History of total pancreatectomy.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Shounak Majumder, M.D.

Open for enrollment

Contact information:

Adriana Delgado M.A., CCRP

(507) 244-5001


More information


Publications are currently not available

Mayo Clinic Footer